ATH 0.00% 0.5¢ alterity therapeutics limited

Approved drugs with CNS demyelination side effect., page-28

  1. 1,560 Posts.
    lightbulb Created with Sketch. 2
    ... and no use reporting you for being a thoughtless and biased investor who labels posts as stupid if they do not copy nine-year-old abstracts by researchers who have nothing to do with Prana.

    BTW the UK and Europe will do no negotiating. It is up to the sponsor to present data of a worthwhile therapeutic and to following the regulators' agenda to a T. If that is not done, another POOF.

    I am very happy that you will waste no more time on my rubbish. Promise?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.